-
-
-
-
-
-
-
Zealand Pharma Announces Financial Results for the First Half of 2025
-
-
-
-
-
-
-
Zealand Pharma Announces Financial Results for the First Nine Months of 2024
-
-
-
-
-
-
-
Zealand Pharma Announces Financial Results for the First Nine Months of 2023
-
-
-
-
-
-
-
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
-
-
-
-
-
-
-
Correction: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
-
-
-
-
-
-
-
Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas
-
-
-
-
-
-
-
Zealand Pharma announces update to 2020 financial guidance
-
1,197,259 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

